Akash Mourya | Health and Medicine Advances | Best Researcher Award

Published on by New Scientists

Mr. Akash Mourya | Health and Medicine Advances | Best Researcher Award

PhD Scholar | National Institutes of Pharmaceutical Education and Research | India

Mr. Akash Mourya is a promising young pharmacologist specializing in pharmacology and toxicology, with a strong research focus on liver pathophysiology, hepatoprotective drug discovery, and molecular mechanisms underlying hepatic and pulmonary disorders. His ongoing Ph.D. work at NIPER Mohali builds on extensive preclinical and translational research conducted at the Institute of Liver and Biliary Sciences (ILBS), New Delhi, where he has developed expertise in animal models of liver diseases, hemodynamic studies, and hepatic cell culture systems. His research contributions have advanced understanding of non-alcoholic and alcoholic fatty liver diseases, hepatopulmonary and porto-pulmonary hypertension, and liver regeneration mechanisms. He has co-authored seven peer-reviewed publications in high-impact journals, including Journal of Hepatology, JHEP Reports, American Journal of Physiology–Gastrointestinal and Liver Physiology, npj Gut and Liver, ACS Omega, and Life Sciences. His work has collectively received 31 citations, 7 Documents, with an h-index of 3, reflecting growing recognition within the biomedical research community. In addition to journal articles, Mr. Akash Mourya has contributed two book chapters published by Springer Nature (2024) and Academic Press (2025), covering topics such as oxidative stress and pharmacological interventions in liver disease, and PPARγ signaling in diabetes. His research abstracts have been presented at prestigious international conferences, including the American Association for the Study of Liver Diseases (AASLD) and the European Association for the Study of the Liver (EASL). His work integrates pharmacological innovation, molecular biology, and experimental therapeutics, with emphasis on Ayurvedic formulations, CB2 receptor agonists, and novel siRNA nanoparticle delivery systems. Mr. Akash Mourya’s ongoing efforts contribute to translational R&D for liver protection and regeneration, aligning with India’s growing emphasis on integrative pharmacology and precision medicine.

Profiles: Scopus | Google Scholar | ResearchGate | PubMed 

Featured Publications

1. Baweja, S., Kumari, A., Negi, P., Tomar, A., Tripathi, D. M., Mourya, A. K., Rastogi, A., Subudhi, P. D., Thangariyal, S., Kumar, G., Kumar, J., Sood, A., Vashistha, C., Bihari, C., Maiwall, R., & Sarin, S. K. (2023). Hepatopulmonary syndrome is associated with low sphingosine-1-phosphate levels and can be ameliorated by the functional agonist fingolimod. Journal of Hepatology, 79(1), 167–180.

2. Juneja, P., Rahman, S. N. R., Jakhar, D., Mourya, A. K., Tripathi, D. M., Kaur, I., Tiwari, V., & others. (2023). Recombinant VEGF-C (Cys156Ser) improves mesenteric lymphatic drainage and gut immune surveillance in experimental cirrhosis. JHEP Reports, 5(10), 100816.

3. Biswas, S., Yadav, N., Juneja, P., Mourya, A. K., Kaur, S., Tripathi, D. M., & Chauhan, V. S. (2022). Conformationally restricted dipeptide-based nanoparticles for delivery of siRNA in experimental liver cirrhosis. ACS Omega, 7(41), 36811–36824.

4. Kaur, I., Juneja, P., Tiwari, R., Vasudevan, A., Mourya, A. K., Trauner, M., Sarin, S. K., & Tripathi, D. M. (2024). Secondary bile acids in portal blood contribute to liver regeneration in a rat model of partial hepatectomy. American Journal of Physiology – Gastrointestinal and Liver Physiology, 327(4), G645–G658.

5. Tripathi, D. M., Singh, P., Mourya, A. K., & Kaur, S. (2024). Oxidative medicine and novel pharmacological treatment approaches in liver disease. In Adaptation under stressful environments through biological adjustments and interventions (pp. 311–334). Springer Nature.

 

Bing Han | Health and Medicine Advances | Best Researcher Award

Published on by New Scientists

Dr. Bing Han | Health and Medicine Advances | Best Researcher Award

Postdoctoral Researcher, The First Affiliated Hospital of Zhengzhou University, China

Dr. Bing Han, Professor at The First Affiliated Hospital of Zhengzhou University, China, is an accomplished medical scientist and clinician whose research bridges molecular biology, microbiome science and clinical gastroenterology. He earned his medical degree (M.D.) followed by postdoctoral research training focused on digestive disease mechanisms and microbial interactions, establishing a strong foundation in translational and precision medicine. His primary research interests center on the gut microbiota–host interaction, bile acid metabolism, intestinal inflammation and biomarker discovery for digestive disorders, with emerging interests in microbiome-based therapeutic interventions. Over his distinguished career, Dr. Bing Han has held academic and clinical roles at The First Affiliated Hospital of Zhengzhou University and collaborated with The First Affiliated Hospital of the University of Science and Technology of China, contributing to interdisciplinary advancements in medical research. His key scientific contributions include innovative studies on the mechanisms of fecal microbiota transplantation in improving inflammatory bowel disease (IBD) and the development of biomedical devices such as spinal positioning systems and femoral defect fixation stents. He has published 9 scientific documents, receiving 50 citations with an h-index of 5 and authored the academic book Frontiers of Tumor Research. Among his notable research supports are the China Postdoctoral Science Foundation Grant, National Natural Science Foundation of China Grant and the Guangxi Natural Science Foundation and Health Commission Projects of Guangxi Zhuang Autonomous Region. His professional engagements include serving as a Young Editorial Board Member for the Journal of Guangxi Medical University and membership in the Digestive Professional Committee of the Chinese Society of Pathophysiology and the Gut Microbiota Branch of the Chinese Society of Biophysics. Through his pioneering research on gut microbiota and digestive pathophysiology, Dr. Bing Han aims to revolutionize clinical diagnostics and therapeutics, promoting global health advancement and innovation in biomedical science.

Profile: Scopus | ORCID | ResearchGate

Featured Publications

1. Han, B., Tang, D., Zhu, H., et al. (2024). Integrated multi-omics reveal gut microbiota-mediated bile acid metabolism regulating immunotherapy responses to anti-α4β7-integrin in Crohn’s disease. Gut Microbes, 16(1), 2310894.

2. Han, B., Li, C., Meng, H., et al. (2019). Efficacy and safety of external-beam radiation therapy for hepatocellular carcinoma: An overview of current evidence according to the different target population. Bioscience Trends, 13(1), 10–22.

3. Han, B., Tang, D., Lv, X., et al. (2023). Comparative efficacy and safety of combination therapy with infliximab for Crohn’s disease: A systematic review and network meta-analysis. International Journal of Colorectal Disease, 38(1), 82.

4. Han, B., Shao, L., Li, C., et al. (2019). Surgery versus external beam radiation therapy for AJCC stage I hepatocellular carcinoma. Journal of BUON, 24(4), 1390–1401.

5. Han, B., Yao, H., Shao, L., et al. (2018). Selection of treatment modalities for hepatocellular carcinoma at stages T1 and T2: A preliminary analysis based on the Surveillance, Epidemiology, and End Results registry database. Journal of BUON, 23(3), 611–621.

 

Jie Wu | Health and Medicine | Best Researcher Award

Published on by New Scientists

Prof. Dr. Jie Wu | Health and Medicine | Best Researcher Award

Professor and Lab Director, Shantou University Medical College, China

Prof. Dr. Jie Wu is a Distinguished Professor and Director of the Laboratory of Brain Function and Disease at Shantou University Medical College, China, and formerly served as Professor and Director of the Neurophysiology Laboratory at the Barrow Neurological Institute (BNI), St. Joseph’s Hospital and Medical Center, USA. He earned his M.D. from Xuzhou Medical College in 1983 and Ph.D. in Neurophysiology from Sun Yat-sen University of Medical Sciences in 1990, followed by postdoctoral fellowships at Tohoku University School of Medicine, Japan (1993–1994), and the University of New Mexico, USA (1994–1997). His research focuses on the physiology and pharmacology of nicotinic acetylcholine receptors (nAChRs), molecular mechanisms of epilepsy, and neurodegenerative disorders related to amyloid beta (Aβ) and receptor dysfunction, as well as ATP-sensitive potassium (KATP) channel regulation. Over three decades, he has led groundbreaking neuroscience research funded by the U.S. National Institutes of Health (NIH), the State of Arizona, and various international foundations, making fundamental discoveries in synaptic receptor signaling and neurodegeneration. His pioneering contributions have led to nearly 200 peer-reviewed publications, five book chapters, and eight patents (four U.S. and four Chinese), providing novel insights into receptor-mediated neurological diseases and translational therapies. Among his many honors, Prof. Dr. Jie Wu has received the China National Natural Science Award and the International HH Rosenfield Rekate Pioneer Award, and was listed among the World’s Top 2% Scientists (2022) and elected as a Fellow of the Royal Society of Arts (FRSA, UK, 2024). He serves as Editor-in-Chief and editorial board member for leading international journals and is active in global neuroscience and biomedical societies. With 161 documents, 5,887 citations and an h-index of 44, Prof. Dr. Jie Wu exemplifies research excellence and leadership, advancing global neuroscience through innovation, collaboration, and mentorship that continues to shape the future of brain science and human health worldwide.

Profile: Scopus | ORCID | Google Scholar | ResearchGate | Sci Profiles | Loop | LONGDOM | LinkedIn 

Featured Publications

1. Zhang, X. X., Gao, M., Liu, Q. R., Bi, G. H., Li, X., Yang, H. J., Gardner, E. L., & Wu, J. (2014). Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice. Proceedings of the National Academy of Sciences of the United States of America, 111(46), E5007–E5015.

2. Liu, Q., Huang, Y., Xue, F., Simard, A., DeChon, J., Li, G., Zhang, J., Lucero, L., & Wu, J. (2009). A novel nicotinic acetylcholine receptor subtype in basal forebrain cholinergic neurons with high sensitivity to amyloid peptides. Journal of Neuroscience, 29(4), 918–929.

3. Wang, T. N., Yang, W., Wang, Y., Nagaraj, V. J., Liu, Q., & Wu, J. (2012). Label-free measuring and mapping of binding kinetics of membrane proteins in single living cells. Nature Chemistry, 4(10), 846–853.

4. Chen, D. J., Gao, M., Gao, F. F., Su, Q. X., & Wu, J. (2017). Brain cannabinoid receptor 2: Expression, function and modulation. Acta Pharmacologica Sinica, 38(3), 312–316.

5. Okada, Y. C., Wu, J., & Kyuhou, S. (1997). Genesis of MEG signals in a mammalian CNS structure. Electroencephalography and Clinical Neurophysiology, 103(4), 474–485.

 

Marwa Matboli | Molecular Biology | Women Researcher Award

Published on by New Scientists

Prof. Dr. Marwa Matboli | Molecular Biology | Women Researcher Award

Marwa Matboli at Faculty of Medicine – Ain Shams University, Egypt.

Prof. Dr. Marwa Matboli is a distinguished Professor of Biochemistry and Molecular Biology at Ain Shams University, Egypt. With a robust academic and research background, she has significantly contributed to the fields of molecular diagnostics, bioinformatics, and translational medicine. Her work encompasses the exploration of non-coding RNAs in disease mechanisms, the application of computational tools in biomedical research, and the development of novel biomarkers for various diseases. She has held several key academic and administrative positions, demonstrating leadership in both educational and research domains.

Publication Profile

Scopus

Orcid

Google Scholar

Educational Details

  • MD in Medical Biochemistry and Molecular Biology, Ain Shams University, November 2012
    Thesis: Proteomic Analysis in Breast Screening Study
    Grade: GPA 3.12

  • MSc in Medical Biochemistry, Ain Shams University, May 2009
    Thesis: Detection of mRNA of Apoptosis Inhibition Gene in Urine of Bladder Cancer
    Grade: Excellent

  • M.B., B.Ch. in Medicine, Ain Shams University, December 2002
    Grade: Excellent 

  • Academic Visitor, St. George’s University of London, 2010–2012

Professional Experience

  • Professor, Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Ain Shams University (2023–Present)

  • Associate Professor, Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Ain Shams University (2018–2023)

  • Lecturer, Department of Medical Biochemistry, Ain Shams University (2013–2018)

  • Assistant Lecturer, Department of Medical Biochemistry, Ain Shams University (2009–2012)

  • Demonstrator, Department of Medical Biochemistry, Ain Shams University (2005–2009)

  • General Practitioner, Ain Shams University Hospitals (2002–2003); Ministry of Health (2003–2004)

  • Coordinator, Medical Biochemistry and Molecular Biology Department, Armed Forces College of Medicine (2016–2017)

  • Coordinator, Biomedical Research Department, Armed Forces College of Medicine (2016–2017)

  • Acting Head, Medical Biochemistry and Molecular Biology Department, Faculty of Medicine, Modern University for Technology and Information (July 2019–2023)

  • Director, Medical Research Unit, Faculty of Medicine, Modern University for Technology and Information (July 2019–September 2023)

  • Professor and Researcher, Molecular Biology Research Lab, Faculty of Oral & Dental Medicine, Misr International University

  • Coordinator, Genetic Module, Ain Shams Faculty of Medicine (2024–Present)

  • Coordinator, Courses in Genetic Engineering, Applied Genomic Technology, Genomics & Proteomics, and Computational Findings, Faculty of Artificial Intelligence, Delta University for Science and Technology (September 2024–Present)

Research Interest

Prof. Dr. Marwa Matboli’s research focuses on:

  • Non-coding RNAs (miRNAs, lncRNAs, circRNAs) in disease diagnostics and therapeutics

  • Bioinformatics and computational biology applications in medical research

  • Molecular mechanisms underlying metabolic disorders, including diabetes and non-alcoholic steatohepatitis

  • Cancer biomarker discovery and validation

  • Integration of machine learning models in biomedical data analysis

She has contributed to multiple international projects, including the development of the MicroRNA Childhood Cancer Catalog (M3Cs) Version 2.0 and the African Genomic Medicine Training Initiative (AGMT) course.

Author Metrics

  • Google Scholar

    • Total Citations: 2,057

    • h-index: 27

    • i10-index: 59

  • Scopus

    • Total Citations: ~1,550

    • h-index: 22

  • ResearchGate

    • Research Interest Score: 1,000.2

  • ORCID Id: 0000-0002-6852-3954

Top Noted Publication

1. Title: Investigation of long noncoding RNAs expression profile as potential serum biomarkers in patients with hepatocellular carcinoma
Authors: Kamel MM, Matboli M, Sallam M, Montasser IF, Saad AS, El-Tawdi AHF
Journal: Translational Research
Volume/Issue/Pages: 168, 134–145
Year: 2016
Impact Factor (2016): ~5.029
Category & Ranking (2016): Medicine, Research & Experimental (Q1)
Citations (Google Scholar): 148
Contribution: Co-author (Prof. Marwa Matboli)

2. Title: Urinary exosomal microRNA panel unravels novel biomarkers for diagnosis of type 2 diabetic kidney disease
Authors: Eissa S, Matboli M, Aboushahba R, Bekhet MM, Soliman Y
Journal: Journal of Diabetes and its Complications
Volume/Issue/Pages: 30(8), 1585–1592
Year: 2016
Impact Factor (2016): ~2.722
Category & Ranking (2016): Endocrinology & Metabolism (Q2)
Citations (Google Scholar): 132
Contribution: Co-author (Prof. Marwa Matboli)

3. Title: Clinical verification of a novel urinary microRNA panel: miR-133b, miR-342, and miR-30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis
Authors: Eissa S, Matboli M, Bekhet MM
Journal: Biomedicine & Pharmacotherapy
Volume/Pages: 83, 92–99
Year: 2016
Impact Factor (2016): ~2.759
Category & Ranking (2016): Pharmacology & Pharmacy (Q2)
Citations (Google Scholar): 119
Contribution: Co-author (Prof. Marwa Matboli)

4. Title: Caffeic acid attenuates diabetic kidney disease via modulation of autophagy in a high-fat diet/streptozotocin-induced diabetic rat
Authors: Matboli M, Eissa S, Ibrahim D, Hegazy MGA, Imam SS, Habib EK
Journal: Scientific Reports
Volume/Article: 7, Article number: 2263
Year: 2017
Impact Factor (2017): ~4.122
Category & Ranking (2017): Multidisciplinary Sciences (Q1)
Citations (Google Scholar): 94
Contribution: First author (Prof. Marwa Matboli)

5. Title: Integrative functional genetic-epigenetic approach for selecting genes as urine biomarkers for bladder cancer diagnosis
Authors: Eissa S, Matboli M, Essawy NOE, Kotb YM
Journal: Tumor Biology
Volume/Pages: 36, 9545–9552
Year: 2015
Impact Factor (2015): ~2.926
Category & Ranking (2015): Oncology (Q3) (Note: The journal was later retracted by the publisher in 2017 for multiple articles due to concerns about peer review integrity)
Citations (Google Scholar): 68
Contribution: Co-author (Prof. Marwa Matboli)

Conclusion

Prof. Dr. Marwa Matboli exemplifies the ideal candidate for the Women Researcher Award in Molecular Biology. Her exceptional scholarly output, academic leadership, and pioneering contributions to RNA biology, computational medicine, and translational diagnostics set her apart as a transformative figure in the biomedical field. By addressing minor visibility gaps at the global level, she can further elevate her profile as a leading international expert.

 

Javad Amini Mahabadi | Stem Cell Research | Best Researcher Award

Published on by New Scientists

Dr. Javad Amini Mahabadi | Stem Cell Research | Best Researcher Award

Javad Amini Mahabadi at Gametogenesis Research Center, Iran.

Dr. Javad Amini Mahabadi is a distinguished Iranian researcher and academic specializing in reproductive biology, stem cells, and assisted reproductive technologies. With a Ph.D. in Reproductive Biology from Kashan University of Medical Sciences, his research focuses on the differentiation of stem cells into germ cells and advancements in IVF and ICSI techniques. He is currently affiliated with multiple leading research institutions, including the Gametogenesis Sciences Research Center and the Sarem Gynecology, Obstetrics and Infertility Research Center. Dr. Amini Mahabadi has contributed extensively to scientific literature and holds a strong academic presence with an h-index of 16 in Google Scholar and 12 in Scopus.

Publication Profile

Scopus

Orcid

Google Scholar

Educational Details

  • Ph.D. in Reproductive Biology (2014–2019)
    Gametogenesis Research Center, Kashan University of Medical Sciences, Kashan, Iran
    Ph.D. Thesis: The effect of estrogen, progesterone, and testosterone with retinoic acid on differentiation of mouse induced pluripotent stem cells (miPSCs) to primordial germ cells-like (PGCs-like).

  • M.Sc. in Animal Physiology (2008–2011)
    Department of Animal Sciences, University of Zanjan, Zanjan, Iran
    M.Sc. Thesis: The effect of sesame seed regimen on the reproductive system of adult male rats.

  • B.Sc. in Animal Science (2003–2007)
    Department of Animal Science, Razi University, Kermanshah, Iran.

Professional Experience

Dr. Amini Mahabadi has a diverse professional background in academia and research. He has served as a university lecturer and has actively participated in organizing and leading various scientific workshops on topics including stem cell culture, sperm analysis, scientific writing, and research proposal development. He also worked as a Supervisor Engineer in a poultry production company and held an administrative role at Nain University. His hands-on training includes:

  • Stem cell culture at the Stem Cell Technology Research Center (Bonyakhteh), 2016

  • IVF and ICSI techniques at Beheshti Hospital, Kashan, 2017

  • ART techniques training at Sarem Fertility and Infertility Research Center (SAFIR), 2020

Research Interest

  • Reproductive Biology

  • In Vitro Fertilization (IVF) & Intracytoplasmic Sperm Injection (ICSI)

  • Stem Cell Research and Differentiation

  • Medical Genetics

  • Histopathology

  • Physiology

  • Animal Science

Author Metrics

  • h-index (Google Scholar): 16

  • h-index (Scopus): 12

Top Noted Publication

1. Protective effect of Pumpkin seed extract on sperm characteristics, biochemical parameters and epididymal histology in adult male rats treated with Cyclophosphamide

Authors: S. Aghaei, H. Nikzad, M. Taghizadeh, A.A. Tameh, A. Taherian, A. Moravveji
Journal: Andrologia
Volume/Issue/Page: 46(8), 927–935
Year: 2014
Citation Count: 79
Summary: This study investigates the protective effects of pumpkin seed extract on sperm parameters, biochemical markers, and histological features in cyclophosphamide-treated male rats, suggesting potential fertility-preserving benefits.

2. Effects of herbal medicine on male infertility

Authors: F. Mohammadi, H. Nikzad, A. Taherian, J. Amini Mahabadi, M. Salehi
Journal: Anatomical Sciences Journal
Volume/Issue/Page: 10(4), 3–16
Year: 2013
Citation Count: 78
Summary: A review paper evaluating the therapeutic potential of various herbal medicines in treating male infertility, focusing on mechanisms of action and experimental/clinical findings.

3. PCL/PVA nanofibrous scaffold improve insulin-producing cells generation from human induced pluripotent stem cells

Authors: M.F. Abazari, F. Soleimanifar, M.N. Aleagha, S. Torabinejad, N. Nasiri, et al.
Journal: Gene
Volume/Page: 671, 50–57
Year: 2018
Citation Count: 64
Summary: This study demonstrates that electrospun PCL/PVA nanofibrous scaffolds enhance the generation of insulin-producing cells from hiPSCs, providing insights into diabetes regenerative therapies.

4. Improved osteogenic differentiation of human induced pluripotent stem cells cultured on polyvinylidene fluoride/collagen/platelet‐rich plasma composite nanofibers

Authors: M.F. Abazari, F. Soleimanifar, M. Amini Faskhodi, R.N. Mansour, et al.
Journal: Journal of Cellular Physiology
Volume/Issue/Page: 235(2), 1155–1164
Year: 2020
Citation Count: 54
Summary: The paper shows that composite nanofiber scaffolds made of PVDF, collagen, and PRP significantly enhance osteogenic differentiation of hiPSCs, relevant for bone tissue engineering.

5. MicroRNA incorporated electrospun nanofibers improve osteogenic differentiation of human induced pluripotent stem cells

Authors: A.S.M. Aylin Tahmasebi, S.E. Enderami, E. Saburi, M. Islami, et al.
Journal: Journal of Biomedical Materials Research Part A
Volume/Issue/Page: 108(2), 377–386
Year: 2019
Citation Count: 51
Summary: This paper highlights how incorporating osteo-inductive microRNAs into electrospun nanofibers improves the differentiation of hiPSCs toward bone-forming cells.

Conclusion

Dr. Javad Amini Mahabadi exemplifies the qualities of a dedicated, productive, and impactful researcher in the fields of reproductive biology and stem cell technology. His diverse academic background, meaningful publication record, and interdisciplinary approach make him a strong and deserving nominee for the Best Researcher Award in biomedical and health sciences.

With continued efforts toward international collaborations, independent research leadership, and technological innovation, his future potential is even more promising.